# Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker

> **NCT01444833** · NA · UNKNOWN · sponsor: **Slovak Academy of Sciences** · enrollment: 35 (estimated)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Candesartan

## Key facts

- **NCT ID:** NCT01444833
- **Lead sponsor:** Slovak Academy of Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-10
- **Primary completion:** 2009-03
- **Final completion:** 2012-12
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2011-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01444833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01444833, "Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01444833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*